Estrogen receptor-beta expression in hereditary breast cancer

被引：15

作者：

Daidone, MG

Veneroni, S

Cappelletti, V

Pierotti, MA

Younes, M

机构：

[1] Ist Nazl Tumori, Fdn Italia Ricerca Cancro, Inst Mol Oncol, I-20133 Milan, Italy

[2] Baylor Coll Med, Houston, TX 77030 USA

来源：

JOURNAL OF CLINICAL ONCOLOGY | 2002年 / 20卷 / 17期

关键词：

D O I：

10.1200/JCO.2002.99.116

中图分类号：

R73 [肿瘤学];

学科分类号：

100214 ;

摘要：

引用

页码：3752 / 3753

页数：2

共 10 条

[1]

Chang J, 2001, CLIN CANCER RES, V7, P1739

[2] Role of direct interaction in BRCA1 inhibition of estrogen receptor activity [J].

Fan, SJ ;

Ma, YX ;

Wang, CG ;

Yuan, RQ ;

Meng, QH ;

Wang, JA ;

Erdos, M ;

Goldberg, ID ;

Webb, P ;

Kushner, PJ ;

Pestell, RG ;

Rosen, EM .

ONCOGENE, 2001, 20 (01) :77-87

[3] The estrogen receptor β-isoform (ERβ) of the human estrogen receptor modulates ERα transcriptional activity and is a key regulator of the cellular response to estrogens and antiestrogens [J].

Hall, JM ;

McDonnell, DP .

ENDOCRINOLOGY, 1999, 140 (12) :5566-5578

[4] The pathology of familial breast cancer:: Predictive value of immunohistochemical markers estrogen receptor, progesterone receptor, HER-2, and p53 in patients with mutations in BRCA1 and BRCA2 [J].

Lakhani, SR ;

van de Vijver, MJ ;

Jacquemier, J ;

Anderson, TJ ;

Osin, PP ;

McGuffog, L ;

Easton, DF .

JOURNAL OF CLINICAL ONCOLOGY, 2002, 20 (09) :2310-2318

[5]

Loman N, 1998, CANCER, V83, P310, DOI 10.1002/(SICI)1097-0142(19980715)83:2<310::AID-CNCR15>3.0.CO

[6]

2-W

[7] Estrogen receptor beta expression in invasive breast cancer [J].

Mann, S ;

Laucirica, R ;

Carlson, N ;

Younes, PS ;

Ali, N ;

Younes, A ;

Li, Y ;

Younes, M .

HUMAN PATHOLOGY, 2001, 32 (01) :113-118

[8] Tamoxifen and risk of contralateral breast cancer in BRCA1 and BRCA2 mutation carriers:: a case-control study [J].

Narod, SA ;

Brunet, JS ;

Ghadirian, P ;

Robson, M ;

Heimdal, K ;

Neuhausen, SL ;

Stoppa-Lyonnet, D ;

Lerman, C ;

Pasini, B ;

de los Rios, P ;

Weber, B ;

Lynch, H .

LANCET, 2000, 356 (9245) :1876-1881

[9] Estrogen receptor β acts as a dominant regulator of estrogen signaling [J].

Pettersson, K ;

Delaunay, F ;

Gustafsson, JÅ .

ONCOGENE, 2000, 19 (43) :4970-4978

[10] Outcome of preventive surgery and screening for breast and ovarian cancer in BRCA mutation carriers [J].

Scheuer, L ;

Kauff, N ;

Robson, M ;

Kelly, B ;

Barakat, R ;

Satagopan, J ;

Ellis, N ;

Hensley, M ;

Boyd, J ;

Borgen, P ;

Norton, L ;

Offit, K .

JOURNAL OF CLINICAL ONCOLOGY, 2002, 20 (05) :1260-1268

← 1 →